Geode Capital Management
LUMO

Geode Capital Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Geode Capital Management’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-55,148
Closed -$213K – 4539
2024
Q3 		$213K Buy
55,148
+4,421
+9% +$12.2K ﹤0.01% 3878
2024
Q2 		$118K Buy
50,727
+3,131
+7% +$8.09K ﹤0.01% 4092
2024
Q1 		$134K Hold
47,596
– – ﹤0.01% 4065
2023
Q4 		$149K Hold
47,596
– – ﹤0.01% 4044
2023
Q3 		$157K Sell
47,596
-6,683
-12% -$20.8K ﹤0.01% 4079
2023
Q2 		$179K Buy
54,279
+20,023
+58% +$70.7K ﹤0.01% 4092
2023
Q1 		$116K Hold
34,256
– – ﹤0.01% 4290
2022
Q4 		$123K Buy
34,256
+1,754
+5% +$11.5K ﹤0.01% 4317
2022
Q3 		$287K Hold
32,502
– – ﹤0.01% 4010
2022
Q2 		$250K Buy
32,502
+429
+1% +$3.43K ﹤0.01% 4135
2022
Q1 		$303K Buy
32,073
+3,725
+13% +$33.3K ﹤0.01% 4180
2021
Q4 		$196K Sell
28,348
-8
-0% -$67 ﹤0.01% 4482
2021
Q3 		$269K Buy
28,356
+5,164
+22% +$48.5K ﹤0.01% 4315
2021
Q2 		$230K Hold
23,192
– – ﹤0.01% 4285
2021
Q1 		$271K Hold
23,192
– – ﹤0.01% 4019
2020
Q4 		$828K Hold
23,192
– – ﹤0.01% 3420
2020
Q3 		$320K Hold
23,192
– – ﹤0.01% 3577
2020
Q2 		$382K Buy
23,192
+681
+3% +$8.11K ﹤0.01% 3465
2020
Q1 		$191K Sell
22,511
-481
-2% -$6.72K ﹤0.01% 3564
2019
Q4 		$523K Sell
22,992
-30
-0.1% -$428 ﹤0.01% 3483
2019
Q3 		$329K Sell
23,022
-7,296
-24% -$107K ﹤0.01% 3614
2019
Q2 		$403K Sell
30,318
-23,902
-44% -$361K ﹤0.01% 3543
2019
Q1 		$941K Sell
54,220
-1,086
-2% -$16.2K ﹤0.01% 3185
2018
Q4 		$756K Buy
55,306
+1,660
+3% +$29.2K ﹤0.01% 3225
2018
Q3 		$1.15M Buy
53,646
+14,797
+38% +$450K ﹤0.01% 3163
2018
Q2 		$1.66M Buy
38,849
+12,288
+46% +$563K ﹤0.01% 2961
2018
Q1 		$1.73M Buy
26,561
+341
+1% +$24.2K ﹤0.01% 2842
2017
Q4 		$1.91M Buy
26,220
+4,033
+18% +$334K ﹤0.01% 2778
2017
Q3 		$2.03M Sell
22,187
-1,528
-6% -$117K ﹤0.01% 2741
2017
Q2 		$1.57M Buy
23,715
+2,259
+11% +$280K ﹤0.01% 2875
2017
Q1 		$4.65M Buy
21,456
+3,866
+22% +$552K ﹤0.01% 2159
2016
Q4 		$1.63M Buy
17,590
+1,343
+8% +$151K ﹤0.01% 2745
2016
Q3 		$2.2M Sell
16,247
-394
-2% -$39.1K ﹤0.01% 2507
2016
Q2 		$1.69M Sell
16,641
-1,279
-7% -$159K ﹤0.01% 2589
2016
Q1 		$2.94K Buy
17,920
+929
+5% +$188K ﹤0.01% 2200
2015
Q4 		$5.56M Buy
16,991
+529
+3% +$172K ﹤0.01% 1796
2015
Q3 		$5.31M Buy
16,462
+593
+4% +$261K ﹤0.01% 1804
2015
Q2 		$6.32M Buy
15,869
+515
+3% +$219K ﹤0.01% 1742
2015
Q1 		$7.56M Buy
15,354
+2,330
+18% +$903K ﹤0.01% 1585
2014
Q4 		$4.66M Buy
13,024
+336
+3% +$100K ﹤0.01% 1858
2014
Q3 		$2.45M Buy
12,688
+1,705
+16% +$375K ﹤0.01% 2243
2014
Q2 		$2.62M Buy
10,983
+2,035
+23% +$414K ﹤0.01% 2204
2014
Q1 		$2.29M Buy
8,948
+597
+7% +$183K ﹤0.01% 2258
2013
Q4 		$1.65M Buy
8,351
+257
+3% +$45.7K ﹤0.01% 2416
2013
Q3 		$1.37M Buy
8,094
+304
+4% +$48.9K ﹤0.01% 2404
2013
Q2 		$1.38M Buy
+7,790
New +$1.1M ﹤0.01% 2272

Geode Capital Management's LUMO Position: Q4 2024 in Review

Geode Capital Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2024, closing a stake of 55,148 shares — an estimated $213K sold.

Geode Capital Management first reported a position in LUMO in Q2 2013 and held it in 46 quarters. The position peaked at $7.56M in Q1 2015. 0 funds tracked by Wall St. Rank hold LUMO as of Q4 2024.

  • Geode Capital Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Geode Capital Management sold 55,148 Lumos Pharma, Inc. Common Stock shares in Q4 2024, an estimated $213K.
  • Geode Capital Management first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 46 quarters.
  • Geode Capital Management's Lumos Pharma, Inc. Common Stock position peaked at $7.56M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2024.

Based on Geode Capital Management's 13F filing for Q4 2024, filed 12 Feb 2025.